Related Experiment Video
Updated: Jul 11, 2026

Fused Filament Fabrication (FFF) of Metal-Ceramic Components
Published on: January 11, 2019
Sintering of wax for controlling release from pellets
Reena Singh1, S S Poddar, Amit Chivate
1Principal K. M. Kundnani College of Pharmacy, Cuffe Parade, Mumbai 400005, India.
This study explored how to use thermal sintering and wax to control drug release from pellets. Pellets containing theophylline, a water-soluble drug, were made with different amounts of carnauba wax. The wax was either ground or emulsified before being added to the formulation. Pellets were then thermally sintered at various temperatures and times to see how this affected drug release. The results showed that higher wax concentrations slowed drug release, with the most effective results at 20% wax. Sintering at 100°C for 140 seconds produced the best sustained release. Scanning electron microscopy showed that wax moved internally, increasing its surface area within the pellet matrix. Emulsified wax provided more consistent release than ground wax. The findings suggest that thermal sintering can be an effective method for modifying pellet surfaces to achieve controlled release of water-soluble drugs.
Area of Science:
- Pharmaceutical formulation science
- Drug delivery systems
- Controlled release technology
Background:
Controlled release formulations are widely used in drug delivery to manage the rate of active ingredient release. Prior research has demonstrated that hydrophobic materials can slow dissolution by forming barriers within dosage forms. However, this gap motivated a search for effective methods to incorporate such materials into pellet matrices. Theophylline, a water-soluble drug, is known to dissolve rapidly without additional formulation strategies. No prior work had resolved how to effectively embed waxy substances into pellets to achieve prolonged release. Thermal sintering has been proposed as a potential tool for modifying pellet surfaces. Yet, the specific impact of sintering on wax distribution and drug release remains unclear. This uncertainty drove the need to evaluate sintering parameters in combination with wax incorporation. The study aimed to bridge this knowledge gap by testing wax inclusion and thermal treatment in pellet systems.
Purpose Of The Study:
This study aimed to evaluate the use of thermal sintering in conjunction with wax incorporation to control drug release from pellets. The specific problem addressed was the challenge of achieving prolonged drug release using hydrophobic materials. The researchers proposed to test whether sintering could enhance wax dispersion and improve release profiles. Theophylline was selected as a model drug due to its high solubility and rapid dissolution. The study focused on comparing ground and emulsified wax forms for their ability to slow drug release. The motivation stemmed from the need to develop reliable controlled release systems using simple processing methods. The goal was to determine optimal sintering conditions that would sustain drug release for at least 12 hours. This approach sought to offer a practical solution for controlled release formulation development.
Main Methods:
The researchers prepared pellets using extrusion-spheronization technology. The formulation included theophylline, microcrystalline cellulose, and carnauba wax. Two wax forms were tested: ground and emulsified. Pellet batches contained 4% to 20% wax by weight. After preparation, pellets were subjected to thermal sintering at various temperatures and durations. In vitro release testing was conducted to assess drug dissolution over time. Scanning electron microscopy was used to examine wax distribution within pellets. The study evaluated how different sintering conditions affected wax mobility and surface area. The focus was on determining the optimal temperature and time for sintering to achieve sustained release.
Main Results:
The highest wax concentration tested was 20%, and this formulation showed incomplete drug release after 12 hours. Pellets with 20% emulsified wax released less drug than those with ground wax. Thermal sintering at 100°C for 140 seconds produced the most effective sustained release. Sintered pellets exhibited higher hydrophobicity compared to unsintered controls. Scanning electron microscopy revealed internal wax migration, increasing surface area within the pellet matrix. The drug release rate decreased with increasing wax concentration across all formulations. Pellets prepared with ground wax showed greater variability in release profiles. The optimized sintering conditions significantly improved the consistency of drug release.
Conclusions:
The authors suggest that thermal sintering can enhance wax dispersion within pellets to prolong drug release. The study shows that increasing wax concentration correlates with greater release retardation. Sintering at 100°C for 140 seconds was found to be optimal for achieving sustained release. Emulsified wax formulations produced more consistent release profiles than ground wax. The observed internal wax migration supports the mechanism of action proposed by the researchers. The findings indicate that sintering temperature and duration are critical parameters for controlling release. The results suggest that thermal treatment can be used to modify pellet surfaces for controlled release applications. The study proposes that this approach offers a practical method for improving pellet formulations.
Frequently Asked Questions
Thermal sintering increases wax hydrophobicity and promotes internal wax migration, which reduces drug dissolution rates.
Emulsified wax showed lower standard deviation in release profiles compared to ground wax, suggesting better dispersion.
Sintering at 100°C for 140 seconds was found to be optimal for achieving sustained drug release lasting at least 12 hours.
Scanning electron microscopy revealed wax migration within pellets, increasing internal wax surface area and affecting release.
Pellets with 20% wax showed incomplete drug release after 12 hours, indicating effective release retardation.
The researchers propose that thermal sintering can be used to improve wax dispersion and prolong drug release in pellet systems.
